CN Stock MarketDetailed Quotes

Suzhou Fushilai Pharmaceutical (301258)

Watchlist
  • 34.47
  • +0.13+0.38%
Market Closed Mar 13 15:00 CST
3.16BMarket Cap41.58P/E (TTM)

Suzhou Fushilai Pharmaceutical (301258) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Lipoic acid series147.83M66.02%
Carnosine series33.27M14.86%
艾瑞昔布26.59M11.88%
Phosphatidylcholine series13.32M5.95%
Other business2.9M1.29%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical main business426.01M99.19%
Other business3.46M0.81%

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
Domestic218.24M50.82%
Abroad211.23M49.18%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More